Stress ulcer prophylaxis in critically III patients: Resolving discordant meta-analyses

JAMA

Volumn 275, Issue 4, 1996, Pages 308-314

  Cook, Deborah J ^a,c,d   Reeve, Brenda K ^a   Guyatt, Gordon H ^a   Heyland, Daren K ^a   Griffith, Lauren E ^a   Buckingham, Lisa ^a   Tryba, Michael ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^d ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; SUCRALFATE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; STRESS ULCER;

EID: 0030029997     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.4.308     Document Type: Review

References (117)

1. Zinner MJ, Zuidema GD, Smith PL, et al. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet. 1981;153:214-220.
2. Basso N, Baragani M, Materia A, et al. Cimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients. Am J Surg. 1981;141:339-341.
3. Friedman CJ, Oblinger MJ, Surrat PM, et al. Prophylaxis of upper gastrointestinal hemorrhage in patients requiring mechanical ventilation. Crit Care Med. 1982;10:316-319.
4. Hastings PR, Skillman JJ, Bushnell LS, et al. Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med. 1978;298: 1041-1045.
5. Kahn F, Parekh A, Chitkara R, et al. Results of gastric neutralization with hourly antacids and cimetidine in 320 intubated patients with respiratory failure. Chest. 1981;79:409-412.
6. McAlhany JC, Czaja AJ, Pruitt B. Antacid control of complications from acute gastroduodenal disease after burns. J. Trauma. 1976;16:645-649.
7. Pinilla JC, Oleniuk FH, Reed D, et al. Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients? Crit Care Med 1985;13:646-650.
8. Stothert JC, Siminowitz DA, Dellinger EP, et al. Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg. 1980;192:169-173.
9. Weigelt LA, Aurbakken CM, Geweitz BL, et al. Cimetidine versus antacid in prophylaxis for stress ulceration. Arch Surg. 1981;116:597-601.
10. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987; 107:224-233.
11. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents: Antithrombotic Therapy Consensus Conference III. Chest. 1992; 102(suppl):305S-311S.
12. Shuman RB, Schuster DP, Zuckermann GR. Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med. 1987;106:562-567.
13. Lacroix J, Infante-Rivarde C, Jenicek M, et al. Prophylaxis of upper gastrointestinal bleeding in intensive care units: a meta-analysis. Crit Care Med. 1989;17:862-868.
14. Cook DJ, Witt LG, Cook RJ, et al. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med. 1991;91:519-527.
15. Tryba M. Prophylaxis of stress ulcer bleeding: a meta-analysis. J Clin Gastroenterol. 1991;13(suppl 2):544-555.
16. Cook DJ, Laine LA, Guyatt GH, et al. Nosocomial pneumonia and the role of gastric pH: a meta-analysis. Chest. 1991;100:7-13.
17. Chalmers TC. Commentary on 'Stress ulcer prophylaxis in critically ill patients: a meta-analysis.' ACP J Club. July-August 1992:1.
18. Boissel JP, Blanchard J, Panak E, et al. Considerations for the meta-analysis of randomized clinical trials. Control Clin Trials. 1989;10:254-281.
19. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. Can Med Assoc J. 1988;138:697-703.
20. Naylor AF. Small sample considerations in combining 2×2 tables. Biometrics. 1967;3:349-356.
21. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2:121-145.
22. Borrero E, Margolis IB, Bank S. Antacid versus sucralfate in preventing acute gastrointestinal bleeding. Am J Surg. 1984;148:809-812.
23. Laggner AN, Lenz K, Base W, et al. Prevention of upper gastrointestinal bleeding in long term ventilated patients. Am J Med. 1989;86(suppl 6A):81-84.
24. Borrero E, Bank S, Margolis IB, et al. Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. Am J Med. 1985;79(suppl 2C):62-64.
25. Laggner AN, Lenz K, Graninger W, et al. Stressblutungsprophylaxe auf einer internen Intensivstation: Sucralfat versus Ranitidin. Anaesthesist. 1988;37:704-710.
26. Jones RH, Rudge CJ, Bewick M, et al. Cimetidine: prophylaxis against upper gastrointestinal hemorrhage after renal transplant. BMJ. 1978;1: 398-400.
27. Schiessel R, Starlinger M, Wolf A, et al. Failure of cimetidine to prevent gastroduodenal ulceration and bleeding after renal transplantation. Surgery. 1981;90:456-458.
28. Lacroix J, Infante-Rivard C, Gauthier M, et al. Upper gastrointestinal tract bleeding acquired in a pediatric intensive care unit: prophylaxis trial with cimetidine. J Pediatr. 1986;108:1015-1018.
29. Lopez-Herce J, Dorao P, Elola P, Delgado MA, Ruza F, Madero R, for the Gastrointestinal Hemorrhage Study Group. Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and sucralfate. Crit Care Med. 1992;20:1082-1089.
30. Grau JM, Casademont J, Fernandez-Sola J, et al. Prophylaxis of gastrointestinal tract bleeding in patients admitted to a general hospital ward. Scand J Gastroenterol. 1993;28:244-248.
31. Holzapfel L, Charreyre S, Aguilera D, et al. Nosocomial pneumonia in patients given ranitidine. Intensive Care Med. 1988;6(suppl):54.
32. Cartier F, Gauthier-Lafaye P, Lareng L, Mottin J, Cara M, Passalecq J. Cimetidine in patients at risk of stress ulcers: a multi-centre controlled trial. Intensive Care Med. 1980;6(suppl):A54. Abstract.
33. Kapsteir I, Schulgen G, Friedrich T, et al. Incidence of pneumonia in mechanically ventilated patients treated with sucralfate or cimetidine as prophylaxis for stress bleeding: bacterial colonization of the stomach Am J Med. 1991;91(suppl 24): 125S-131S.
34. Breucha G, Imhof M. Pirenzepin in der Allgemeinchirurgie. In: Tryba M, ed. Rationale Stressblutungsprophylaxe. Stuttgart, Germany: Georg Thieme Verlag; 1987:81-88.
35. Tryba M, Zevounou F, Wruck G. Stressblutungen und postoperative Pneumonien bei Intensivpatienten unter Ranitidin oder Pirenzepin. Dtsch Med Wochenschr. 1988;113:930-936.
36. Mattes P, Peros S, Belohiavek D, Malfertheiner P, Herfarth C. Stressulkus-prophylaxe mit Pirenzepin - eine kontrollierte Studie. Z Gastroenterol. 1980;18:320-327.
37. Barandun J, Leutenegger A, Frutiger A, Ruedi T, Kobler E. Prophylaxe gastroduodenaler Stresslasionen bei intensivpflegebedurftigen Unfallpatienten mit Sekretionshemmern: Inzidenz von Lasionen und Nebenwirkungen; Konsequenzen. Schweiz Med Wochenschr. 1985;115:1022-1023.
38. More DG, Raper RF, Watson CJ, et al. Combination therapy with ranitidine and pirenzepine for control of intragastric pH in the critically ill. Crit Care Med. 1985;13:651-655.
39. Jmelnitzky AC, Moday MC, Gallardo EA, et al. Prophylaxis of acute gastric hemorrhage from stress-induced lesions - comparison of pirenzipine and cimetidine in intensive care units. Dig Dig Sci. 1986;31:A814. Abstract.
40. Tryba M, Zevounou F, Torok M, et al. Prevention of acute stress bleeding with sucralfate, antacid or cimetidine. Am J Med. 1985;79(suppl 2C): 55-61.
41. Zinner MJ, Rypins EB, Martin L, et al. Misoprostol versus antacid titration for preventing stress ulcers in postoperative surgical ICU patients. Ann Surg. 1989;210:590-595.
42. 2 does not prevent gastrointestinal bleeding in seriously ill patients. Am J Surg. 1984;147:451-455.
43. 2 and the prevention of gastrointestinal hemorrhage in ICU patients. Crit Care Med. 1985;13:957-960.
44. Martin LF, Booth FVM, Reines D, et al. Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg. 1992;215: 332-337.
45. Martin LF. Stress ulcers are common after aortic surgery: endoscopic evaluation of prophylactic therapy. Am Surg. 1994;60:169-174.
46. Engelhardt D, Karl R, Kobl HJ, et al. Vergleich von Cimetidin-Pirenzepin Antacida zur Stressblutungsprophylaxe bei Intensivepatienten. Dtsch Med Wochenschr. 1985;110:908-914.
47. Holzapfel L, Daveau L, Coupry A, et al. Rôle de la prevention des hemorragies gastroduodenales de stress sur la colonisation gastrique et la survenue d'une pneumopathie nosocomiale chez le malade sous ventilation mécanique. Rean Soins Intens Med Urg. 1990;6:141-145.
48. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med. 1994;120:653-662.
49. Pickworth KK, Falcone RE, Hoogeboom JE, et al. Incidence of nosocomial pneumonia in mechanically ventilated trauma patients: a comparison of sucralfate and ranitidine. Crit Care Med. 1992;20 (suppl):595.
50. Garcia-Labattut A, Rodriquez-Munos S, Gobernado-Serrano M, et al. Sucralfate versus cimetidine in the stress bleeding prophylaxis. Intensive Care Med. 1990;16(Suppl):519.
51. Karlstadt R, Herson J, Palmer R, et al. Cimetidine reduces upper gastrointestinal bleeding and nosocomial pneumonia in intensive care unit patients. Am J Gastroenterol. 1989;84:A:93. Abstract.
52. Reusser P, Gyr K, Scheidegger D, et al. Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis. Crit Care Med. 1990;18:270-274.
53. Reusser P, Zimmerli W, Scheidegger D, et al. Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation. J Infect Dis. 1989;160:414-421.
54. Brandao A, Alvares-da-silva MR, Sibemberg J, et al. Ranitidina na profilaxia da hemorragia digestiva superior por ulceracoes de 'stress.' Gastrointest Esophageal Dis. 1991;10:105-110.
55. Klein HJ. Stressulkus - kausale oder symptomatische Prophylaxe? In: Tryba M, ed. Rationale Stressblutungsprophylaxe. Stuttgart, Germany: Georg Thieme Verlag; 1987:66-76.
56. Ditschuneit H, Malferheiner P. Medikamentose Pravention stressinduzierter Schleimhautlasionen im Magen-darm-trakt. Med Weldt Bd. 1982;33:78-82.
57. Apte NM, Karnad PR, Medhekar TP, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med. 1992;20;590-593.
58. Eddleston JM, Vohra A, Scott P, et al. A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate- or ranitidine-treated intensive care unit patients. Crit Care Med. 1991;19:1491-1496.
59. Moscona R, Kaufman T, Jacobs R, et al. Prevention of gastrointestinal bleeding in burns: the effects of cimetidine or antacids combined with early enteral feeding. Burns. 1985;12:65-67.
60. Noseworthy TRW, Shustack A, Johnston RG, et al. A randomized clinical trial comparing ranitidine and antacids in critically ill patients. Crit Care Med. 1987;15:817-819.
61. Tryba M. Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids. Am J Med. 1987;83(suppl 3B):117-124.
62. Kingsley AN. Prophylaxis for acute stress ulcers: antacids or cimetidine. Am Surg. 1985;51:545-547.
63. Mundinger GH, Hays A, Allo M, et al. Effect of meciadanol and sucralfate as compared with antacid titration regimen on prevention of acute gastrointestinal hemorrhage in post-operative intensive care patients. Surg Forum. 1985;36:121-123.
64. Bresalier RS, Grendell JH, Cello JP, et al. Sucralfate suspension versus titrated antacids for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med. 1987;83(suppl 3B):110-116.
65. Cannon LA, Heiselman DE, Gardner WG, et al. Prophylaxis of upper gastrointestinal tract bleeding in mechanically ventilated patients. Arch Intern Med. 1987;147:2101-2106.
66. MacDougall BRD, Bailey RJ, Williams R. H-2 receptor antagonists and antacids in the prevention of acute gastrointestinal hemorrhage in fulminant hepatic failure. Lancet. 1977;1:617-619.
67. Polesky MH, Spanier AH. Cimetidine versus antacids in the prevention of stress erosions in critically ill patients. Am J Gastroenterol 1986;81:107-111.
68. Priebe HJ, Skillman JJ, Busnnell LS, et al. Antacid versus cimetidine in preventing acute gastrointestinal bleeding. N Engl J Med. 1980;302:426-430.
69. McElwee HP, Sirinek KR, Levine BA. Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury. Surgery. 1979;86:620-626.
70. Karlstadt RG, Iberti TJ, Silverstein J, et al. Comparison of cimetidine and placebo for the prophylaxis of upper gastrointestinal bleeding due to stress-related gastric mucosal damage in the intensive care unit. J Intensive Care Med. 1990;5:26-32.
71. Van den Berg B, Van Blankenstein M. Prevention of stress-induced gastrointestinal bleeding by cimetidine in patients on assisted ventilation. Digestion. 1985;31:1-8.
72. Groll A, Simon JB, Wigle RD, et al. Cimetidine prophylaxis for gastrointestinal bleeding in an intensive care unit. Gut. 1986;27:135-140.
73. Halloran LG, Zfass AM, Gayle WE. Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis. Am J Surg. 1980;139:44-48.
74. Israsena S, Kladcharoen N, Limthongkul S, et al. Sucralfate versus antacid in the prevention of stress ulcer bleeding in patients on mechanical ventilation. J Med Assoc Thai. 1987;70:678-682.
75. Peura DA, Johnson LF. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med. 1985;103:173-177.
76. Borerro E, Ciervo J, Chang JB. Antacid versus sucralfate in preventing acute gastrointestinal tract bleeding in abdominal-aortic surgery. Arch Surg. 1986;121:810-812.
77. Simms HH, DeMaria E, McDonald L, et al. Role of gastric colonization in the development of pneumonia in critically ill trauma patients: results of a prospective randomized trial. J Trauma. 1991; 31:531-537.
78. Mahul P, Auboyer C, Jospe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med. 1992;18:20-25.
79. Labattut AG, Santolalla PM, Andres AP, et al. Efficacy of sucralfate in the prevention of upper gastrointestinal stress bleeding in intensive care patients: comparison vs a control group. Clin Intensive Care. 1992;3:519-525.
80. Ruiz-Santana S, Ortiz E, Gonzalez B, et al. Stress-induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: frequency, complications, and the value of prophylactic treatment: a prospective, randomized study. Crit Care Med. 1991;19:887-891.
81. Knight-George AB, Bihari DJ. Gastric intramural pH and stress ulcer prophylaxis in critically ill patients. Clin Intensive Care. 1990;1:249-255.
82. Martin LP, Max MH, Polk HC. Failure of gastric pH control by antacids or cimetidine in the critically ill: a valid sign of sepsis. Surgery. 1980; 88:59-68.
83. Eddleston JM, Pearson RC, Holland J, Tooth JA, Vohra A, Doran BH. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo. Crit Care Med. 1994;22:1949-1954.
84. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: a randomized controlled single blind study. Ann Intern Med. 1994; 121:568-575.
85. Martin LF, Booth FVM, Karlstadt RG, et al. Continuous intravenous cimeditine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med. 1993;21:19-30.
86. Luk GD, Summer WR, Messersmith JF, et al. Cimetidine and antacid in prophylaxis of acute gastrointestinal bleeding: a randomized, double-blind, controlled study. Gastroenterology. 1982;82:1121. Abstract.
87. Driks MR, Craven DE, Bartolome RC, et al. Nosocomial pneumonia in intubated patients give sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med. 1987;317:1376-1382.
88. Sirvent JM, Verdaguer R, Ferrer MJ, et al. Nosocomial pneumonia and stress ulcer prophylaxis in intubated patients: comparative study of antacids and ranitidine versus sucralfate. Intensive Care Med. 1992:S186.
89. Maier RV, Mitchell D, Gentilello L. Optimal therapy for stress gastritis. Ann Surg. 1994;220: 353-363.
90. Metz CA, Livingston DH, Smith JS, Larson GM, Wilson TH. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress related upper gastrointestinal bleeding: a prospective, multicenter, double-blind, randomized trial. Crit Care Med. 1993;21:1844-1849.
91. Mustafa NA, Akturk G, Ozen I, et al. Acute stress bleeding prophylaxis with sucralfate versus ranitidine and incidence of secondary pneumonia in intensive care unit patients. Intensive Care Med. 1994;21:287.
92. 2 blockers or carafate bid for the prophylaxis of stress ulcers in the ICU. Crit Care Med. 1993; 21(suppl):S181.
93. Thomason M, Reeves R, Payseur E, et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, ranitidine and antacid. Crit Care Med. 1995;23:A93. Abstract.
94. Palomar M, Alvarez F, Jorda R, et al. Nosocomial pneumonia: selective digestive decontamination and sucralfate. Intensive Care Med. 1992;18 (suppl):S58.
95. Ephgrave K, Kleiman-Wexler R, Pfaller M, et al. Results of a double-blind, double-sham study of antacids versus sucralfate stress ulcer prophylaxis. Crit Care Med. 1993;21(suppl):S253.
96. Ryan P, Dawson J, Teres D, et al. Nosocomial pneumonia during stress ulcer prophylaxis with cimetidine and sucralfate. Arch Surg. 1933;128:1353-1357.
97. Fabian TC, Boucher BA, Croce MA, et al. Pneumonia and stress ulceration in severely injured patients. Arch Surg. 1993;128:185-192.
98. Cioffi WG, McMannus AT, Rue LW, et al. Comparison of acid neutralizing and non-acid neutralizing stress ulcer prophylaxis in thermally injured patients. J Trauma. 1994;36:541-547.
99. Cheadle WG, Vitale GC, Mackie CR, et al. Prophylactic postoperative nasogastric decompression. Ann Surg. 1985;202:361-366.
100. Chalmers TC, Berrier J, Sacks HS, Levin H, Reitman D, Nagalingam R. Meta-analysis of clinical trials as a scientific discipline: replicate variability and comparison of studies that agree and disagree. Stat Med. 1987;6:733-744.
101. Easterbrook PJ. Directory of registries of clinical trials. Stat Med. 1992;15:345-359.
102. Dickersin K. Why register clinical trials? - revisited. Control Clin Trials. 1992;13:170-177.
103. Berlin JA. Will publication bias vanish in an age of online journals? Online J Curr Clin Trials 1992. Document 12.
104. Lau J, Antamn EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248-254.
105. Vandenbrouke-Grauls CMJE, Vandenbrouke JP. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet. 1991; 338:859-862.
106. Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Meta-analysis of randomized controlled trials of selective decontamination of the digestive tract. BMJ. 1993;307: 525-532.
107. Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections: a meta-analysis. Chest. 1994;105:1101-1108.
108. Heyland DK, Cook DJ, Jaeschke R, Griffith L, Lee H, Guyatt GH. Selective decontamination of the digestive tract: an overview. Chest. 1994;105: 1221-1229.
109. Rennie D, Flanagin A. Publication bias: the triumph of hope over experience. JAMA. 1992;267: 411-412.
110. Cook DJ, Guyatt GH, Ryan G, Clifton J, Oxman AD. Should unpublished data be included in meta-analyses? current convictions and controversies. JAMA. 1993;269:2749-2753.
111. Chalmers I, Dickerson K, Chalmers TC. Getting to grips with Archie Cochrane's agenda. BMJ 1992;305:786-788.
112. Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized controlled trials in health care: the Potsdam Consultation on Meta-analysis. J Clin Epidemiol. 1995;48:167-171.
113. Andrews CP, Coalson JJ, Smith JD, Johanson WG Jr. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest. 1981;80:254-258.
114. Bell RG, Coalson JJ, Smith JD, et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med. 1983; 99:293-298.
115. Pingleton SK, Fagon JY, Leeper KV, for the Diagnosis Group. Patient selection for clinical investigation of ventilator-associated pneumonia. Chest. 1992;102(suppl):553S-556S.
116. Cook DJ, Fuller H, Guyatt GH, et al, for the Canadian Critical Care Trials Group. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330:377-381.
117. Tryba M. The gastropulmonary route of infection: fact or fiction? Am J Med. 1991;91(suppl 2A):135S-145S.